← back to search

Zhidong Xu

University of California, San Francisco · US
Area of research
Molecular Biology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Wnt/β-catenin signaling in development and cancer, Cancer-related gene regulation, Occupational and environmental lung diseases, and Epigenetics and DNA Methylation.
h-index
49
citations
7,751
works
153
NIH funding
primary concept
email

Recent publications

Microstructure and Wear of W-Particle-Reinforced Al Alloys Prepared by Laser Melt Injection.
2022cited by 5position: contributordoi
Sodium dodecyl sulfate (SDS) as an effective corrosion inhibitor for Mg-8Li-3Al alloy in aqueous NaCl: A combined experimental and theoretical investigation
Journal of Magnesium and Alloys 2021cited by 37position: middledoi
Inhibition of yes‐associated protein down‐regulates PD‐L1 (CD274) expression in human malignant pleural mesothelioma
Journal of Cellular and Molecular Medicine 2018cited by 61position: middledoi
YAP regulates PD-L1 expression in human NSCLC cells
Oncotarget 2017cited by 128position: middledoi
YAP promotes erlotinib resistance in human non-small cell lung cancer cells
Oncotarget 2016cited by 116position: middledoi
YAP1 regulates ABCG2 and cancer cell side population in human lung cancer cells
Oncotarget 2016cited by 54position: middledoi
Inhibition of ERK1/2 down-regulates the Hippo/YAP signaling pathway in human NSCLC cells
Oncotarget 2015cited by 101position: middledoi
Coumestrol from the national cancer Institute’s natural product library is a novel inhibitor of protein kinase CK2
BMC Pharmacology and Toxicology 2013cited by 53position: middledoi
A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies
The Lancet 2012cited by 330position: middledoi
Inhibition of CK2α Down-Regulates Hedgehog/Gli Signaling Leading to a Reduction of a Stem-Like Side Population in Human Lung Cancer Cells
PLoS ONE 2012cited by 73position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Liang You · Guizhou University7 papers (2012–2018)David M. Jablons · UCSF Helen Diller Family Comprehensive Cancer Center7 papers (2012–2018)Yi‐Lin Yang · Shandong University of Technology6 papers (2013–2018)Yuyuan Dai · Jinan University4 papers (2015–2017)Ping‐Chih Hsu · Memorial Hospital of South Bend4 papers (2016–2018)Shu Liu · Guangdong Province Women and Children Hospital3 papers (2013–2016)Yucheng Wang · Institute for Infocomm Research3 papers (2012–2017)Hui Li · Central South University3 papers (2015–2017)David Hsieh · Southwestern Medical Center2 papers (2012–2013)Bin Hu · Shanxi Medical University2 papers (2016–2017)Cheng‐Ta Yang · Shanghai Medical College of Fudan University2 papers (2016–2018)Jinbai Miao · Capital Medical University2 papers (2017–2018)Wenqian Zhang · Central South University2 papers (2016–2016)Bin You · Shanghai University2 papers (2015–2016)Zhen Huang · Guiyang Medical University2 papers (2017–2018) · 1 papers (2022–2022)Osamu Tetsu · UCSF Helen Diller Family Comprehensive Cancer Center1 papers (2015–2015)Honggun Song · Nanchang University1 papers (2021–2021)Joanna You · University of California, San Francisco1 papers (2018–2018)Hong Yan · Nanchang University1 papers (2021–2021)